Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial-authors' reply.
Lancet Reg Health Eur
; 37: 100821, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-38362550
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Lancet Reg Health Eur
Year:
2024
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom